Pathogenesis and treatment of diabetic vascular disease - illustrated by two cases.
This publication is a summary of the presentations given at the First JIM Grand Round held at the Sahlgrenska University Hospital on 15 March 2006. The Grand Round was based on two case reports; a patient with type 2 diabetes and pronounced macrovascular disease and another patient with early microvascular disease combined with the macrovascular complications. The pathogenesis of the vascular complications and the current treatment regimens were discussed in relation to the history and examinations performed in these patients.
Smith
U
U
The Lundberg Laboratory for Diabetes Research, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden. ulf.smith@medic.gu.se
Laakso
M
M
Eliasson
B
B
Wesslau
C
C
Borén
J
J
Wiklund
O
O
Attvall
S
S
D052242:Adiponectin / Q000097:blood; D000789:Angina, Unstable / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D015415:Biomarkers / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008297:Male; D008833:Microcirculation; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D012307:Risk Factors; D016896:Treatment Outcome
D052242:Adiponectin; D015415:Biomarkers; D008076:Cholesterol, HDL